Indeed, CD4+ and CD8+ splenocytes (SPCs) derived from wild type C57BL/6 mice bearing B16 subcutaneous tumors expressed lower levels of miR-17-5p when compared with those derived from non-tumor bearing mice (Fig. 4A). The gene discussed is CD4; the disease is neoplasm.